{"id": "1372725761522601985", "creation": 1616118300.0, "user_id": "1211892441529241601", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 3, "reply_count": 0, "like_count": 2, "quote_count": 1}}, "text": "China has approved emergency use of a self-developed recombinant protein subunit #vaccine against #COVID19. The CHO Cells completed phase 1&amp;2 clinical trials in Oct. 2020. Results support the safety and immunogenicity of this vaccine, with no severe adverse reactions reported. https://t.co/ZPNmk5SYC6", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19"]}